DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,755 filers reported holding DANAHER CORPORATION in Q1 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $55,788,249 | +7.2% | 224,862 | +3.7% | 1.46% | +10.5% |
| Q2 2023 | $52,021,157 | +2.8% | 216,755 | +8.0% | 1.32% | -2.7% |
| Q1 2023 | $50,603,151 | -2.5% | 200,774 | +2.7% | 1.36% | -7.7% |
| Q4 2022 | $51,901,147 | +8.3% | 195,543 | +3.5% | 1.47% | -0.9% |
| Q3 2022 | $47,913,000 | +11.2% | 188,848 | +11.1% | 1.49% | +15.0% |
| Q2 2022 | $43,077,000 | -10.5% | 169,914 | +3.6% | 1.29% | -2.0% |
| Q1 2022 | $48,113,000 | -9.6% | 164,024 | +1.4% | 1.32% | -7.4% |
| Q4 2021 | $53,206,000 | +8.5% | 161,715 | +0.4% | 1.42% | -2.3% |
| Q3 2021 | $49,039,000 | +1.8% | 161,079 | -10.2% | 1.46% | +1.0% |
| Q2 2021 | $48,164,000 | +22.6% | 179,475 | +2.8% | 1.44% | +12.1% |
| Q1 2021 | $39,298,000 | -3.3% | 174,597 | -4.6% | 1.29% | -11.2% |
| Q4 2020 | $40,639,000 | +17.8% | 182,944 | +14.2% | 1.45% | +3.7% |
| Q3 2020 | $34,506,000 | +6.0% | 160,248 | +1.3% | 1.40% | +3.2% |
| Q2 2020 | $32,549,000 | +56.2% | 158,242 | +5.1% | 1.35% | +19.8% |
| Q1 2020 | $20,832,000 | +24.9% | 150,510 | +38.5% | 1.13% | +56.3% |
| Q4 2019 | $16,680,000 | +33.4% | 108,678 | +24.2% | 0.72% | +17.0% |
| Q3 2019 | $12,502,000 | 0.0% | 87,478 | 0.0% | 0.62% | 0.0% |
| Q2 2019 | $12,502,000 | +141.6% | 87,478 | +123.2% | 0.62% | +11.6% |
| Q1 2019 | $5,175,000 | -64.6% | 39,201 | -72.3% | 0.55% | -41.7% |
| Q4 2018 | $14,615,000 | +28.2% | 141,727 | +35.1% | 0.95% | +40.1% |
| Q3 2018 | $11,400,000 | – | 104,910 | – | 0.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |